What is the address of KSB Medical?

The registered office of KSB Medical is located at Grasmarkt 19, 1000 Brussel.

Is KSB Medical still active?

Yes. According to the CBE (3 October 2026) KSB Medical is active, legal situation “Normale toestand”, started on 6 February 2023.

Is KSB Medical registered on Peppol?

Yes, KSB Medical is registered on the Peppol network with ID 0208:0798115307.

What is the enterprise number of KSB Medical?

The enterprise number of KSB Medical is BE0798115307.

When was KSB Medical founded?

KSB Medical was founded on 6 February 2023.

Who are the directors of KSB Medical?

According to the 2025 annual accounts, the directors of KSB Medical are: Alia Majida Kassabeh.

Is KSB Medical a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 February 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did KSB Medical make in 2025?

KSB Medical posted a profit after taxes of € 56,746 in financial year 2025.

What is the revenue of KSB Medical?

As a small company, KSB Medical is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 94,702.

KSB Medical (Private Limited) - Brussel - BE0798115307

Dossier KSB Medical, printed on 3 October 2026 from databakkes.be/en/0798115307/ksb-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

KSB Medical from Brussel, company number BE0798115307, closed financial year 2025 with a result of € 56,746 after tax. For that financial year KSB Medical recorded a gross margin of € 94,702 and equity of € 115,843. Compared with financial year 2024, the result moved from € 48,894 to € 56,746. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.

What it is worth Growing

€ 115,843

▲ 65% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 56,746

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 36,086

▲ 258% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 113,343.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 875 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 875

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 65,601

▲ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,351

▲ 44% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 16,050

▲ € 15,020 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 25,082 Gross margin 2023: € 25,082 First fiscal year in the series	€ 52,460 Gross margin 2024: € 52,460 ▲ 109% vs 2023 (€ 25,082) Favourable step	€ 94,702 Gross margin 2025: € 94,702 ▲ 81% vs 2024 (€ 52,460) Favourable step	▲ 81%
Profit after taxes	€ 19,749 Profit after taxes 2023: € 19,749 First fiscal year in the series	€ 48,894 Profit after taxes 2024: € 48,894 ▲ 148% vs 2023 (€ 19,749) Favourable step	€ 56,746 Profit after taxes 2025: € 56,746 ▲ 16% vs 2024 (€ 48,894) Favourable step	▲ 16%
Equity	€ 21,449 Equity 2023: € 21,449 First fiscal year in the series	€ 70,342 Equity 2024: € 70,342 ▲ 228% vs 2023 (€ 21,449) Favourable step	€ 115,843 Equity 2025: € 115,843 ▲ 65% vs 2024 (€ 70,342) Favourable step	▲ 65%
Total debts	€ 7,906 Total debts 2023: € 7,906 First fiscal year in the series	€ 2,233 Total debts 2024: € 2,233 ▼ 72% vs 2023 (€ 7,906) Favourable step	€ 19,003 Total debts 2025: € 19,003 ▲ € 16,770 vs 2024 (€ 2,233) Unfavourable step	▲ € 16,770
Cash	€ 8,592 Cash 2023: € 8,592 First fiscal year in the series	€ 10,083 Cash 2024: € 10,083 ▲ 17% vs 2023 (€ 8,592) Favourable step	€ 36,086 Cash 2025: € 36,086 ▲ 258% vs 2024 (€ 10,083) Favourable step	▲ 258%
Retained profit	€ 18,949 Retained profit 2023: € 18,949 First fiscal year in the series	€ 67,842 Retained profit 2024: € 67,842 ▲ 258% vs 2023 (€ 18,949) Favourable step	€ 113,343 Retained profit 2025: € 113,343 ▲ 67% vs 2024 (€ 67,842) Favourable step	▲ 67%
Dividend	€ 800 Dividend 2023: € 800 First fiscal year in the series	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 800) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 29,355 Balance sheet total 2023: € 29,355 First fiscal year in the series	€ 72,576 Balance sheet total 2024: € 72,576 ▲ 147% vs 2023 (€ 29,355) Unchanged	€ 134,847 Balance sheet total 2025: € 134,847 ▲ 86% vs 2024 (€ 72,576) Unchanged	▲ 86%

Key figures of KSB Medical, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 May 2027.

What happened to KSB Medical?

What happened at KSB Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 1, 2026 New annual accounts for financial year 2025: profit of € 56,746 (▲ 16% vs 2024). filed late Source: NBB ↗
Feb 6, 2024 New establishment in Sint-Agatha-Berchem. KBO
Feb 6, 2023 New establishment in Ganshoren. KBO
2023 Alia Majida Kassabeh became a director. NBB
Feb 6, 2023 Start of the company according to the CBE. KBO

In short

From € 19,749 profit in 2023 to € 56,746 profit in 2025.

Paid € 20,847 in corporate taxes since 2023.

Best year ever: 2025, with € 56,746 profit.

Paid out € 800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at KSB Medical? We notify you, reason included.

Follow KSB Medical

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Alia Majida Kassabeh

KSB Medical

Behind KSB Medical is Alia Majida Kassabeh.

See the full network in the app

Directors

According to the 2025 annual accounts

Alia Majida Kassabeh

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Grasmarkt 19

1000 Brussel

2.342.537.825

Maria van Hongarijelaan 103

1083 Ganshoren

Active since 6 February 2023

2.355.938.770

Basilieklaan 115 box 1

1082 Sint-Agatha-Berchem

Active since 6 February 2024

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

PERGOBEL

NIMAGROUP-ROSE DE DAMAS

€ 21,440 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0798.115.307
VAT number: BE 0798.115.307
Registered office: Grasmarkt 19, 1000 Brussel
Names & denominations: KSB Medical
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 February 2023
Peppol: Active · Active since 4 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗